Menu Search
Equities

LeMaitre Vascular Inc

LMAT:NMQ

LeMaitre Vascular Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)90.18
  • Today's Change1.33 / 1.50%
  • Shares traded120.64k
  • 1 Year change+56.78%
  • Beta0.8774
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy4
Outperform3
Hold2
Sell0
Strong Sell0

Share price forecast in USD

The 8 analysts offering 12 month price targets for LeMaitre Vascular Inc have a median target of 97.50, with a high estimate of 105.00 and a low estimate of 80.00. The median estimate represents a 8.12% increase from the last price of 90.18.
High16.4%105.00
Med8.1%97.50
Low-11.3%80.00

Dividends in USD

In 2023, LeMaitre Vascular Inc reported a dividend of 0.55 USD, which represents a 12.37% increase over last year. The analyst covering the company expects dividends of 0.64 USD for the upcoming fiscal year, an increase of 17.43%.
Div growth (TTM)12.37%
More ▼

Earnings history & estimates in USD

On Aug 01, 2024, LeMaitre Vascular Inc reported 2nd quarter 2024 earnings of 0.52 per share. This result exceeded the 0.47 consensus of the 9 analysts covering the company and exceeded last year's 2nd quarter results by 44.44%.
The next earnings announcement is expected on Oct 30, 2024.
Average growth rate+10.20%
LeMaitre Vascular Inc reported annual 2023 earnings of 1.34 per share on Feb 27, 2024.
Average growth rate+14.22%
More ▼

Revenue history & estimates in USD

LeMaitre Vascular, Inc. had 2nd quarter 2024 revenues of 55.85m. This bettered the 54.99m consensus of the 9 analysts covering the company. This was 18.64% above the prior year's 2nd quarter results.
Average growth rate+2.89%
LeMaitre Vascular, Inc. had revenues for the full year 2023 of 193.48m. This was 19.69% above the prior year's results.
Average growth rate+13.52%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.